Aterian (NASDAQ:ATER) Releases Earnings Results, Beats Expectations By $0.30 EPS

Aterian (NASDAQ:ATER) released its earnings results on Friday. The company reported ($0.39) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.69) by $0.30, Zacks reports. Aterian had a negative return on equity of 68.00% and a negative net margin of 27.52%.

Aterian Stock Performance

Aterian stock traded down $0.06 during midday trading on Friday, reaching $1.09. 487,062 shares of the company’s stock were exchanged, compared to its average volume of 3,047,473. Aterian has a 52 week low of $0.52 and a 52 week high of $2.10. The firm has a market cap of $11.80 million, a price-to-earnings ratio of -0.45 and a beta of 0.66. The stock’s 50-day simple moving average is $0.74 and its 200 day simple moving average is $0.74.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aterian in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Hedge Funds Weigh In On Aterian

Hedge funds and other institutional investors have recently bought and sold shares of the business. XTX Topco Ltd bought a new position in Aterian during the second quarter worth about $55,000. Goldman Sachs Group Inc. boosted its holdings in shares of Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after acquiring an additional 9,026 shares during the period. Susquehanna International Group LLP boosted its holdings in shares of Aterian by 310.2% during the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after acquiring an additional 30,637 shares during the period. Finally, Citadel Advisors LLC boosted its holdings in shares of Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares during the period. Institutional investors own 7.02% of the company’s stock.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.